tiprankstipranks
Trending News
More News >
Olema Pharmaceuticals (OLMA)
NASDAQ:OLMA
US Market

Olema Pharmaceuticals (OLMA) Income Statement

Compare
958 Followers

Olema Pharmaceuticals Income Statement

Last quarter (Q4 2025), Olema Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Olema Pharmaceuticals's net income was $-46.06M. See Olema Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 178.70M$ 142.26M$ 104.96M$ 106.99M$ 71.49M
Depreciation and Amortization
$ 490.00K$ 393.00K$ 377.00K$ 357.00K$ 163.00K
EBITDA
$ -178.21M$ -141.87M$ -104.58M$ -106.63M$ -71.33M
Operating Income
$ -178.70M$ -142.26M$ -104.96M$ -106.99M$ -71.49M
Other Income/Expenses
$ 16.25M$ 12.78M$ 8.31M$ 2.20M$ 395.00K
Pretax Income
$ -162.45M$ -129.47M$ -96.66M$ -104.79M$ -71.10M
Net Income
$ -162.45M$ -129.47M$ -96.66M$ -104.79M$ -71.10M
Per Share Metrics
Basic EPS
$ -1.87$ -2.20$ -2.14$ -2.62$ -1.79
Diluted EPS
$ -1.87$ -2.20$ -2.14$ -2.62$ -1.79
Weighted Average Shares Outstanding
87.01M 58.74M 45.25M 40.00M 39.52M
Weighted Average Shares Outstanding (Diluted)
87.01M 58.74M 45.25M 40.00M 39.52M
Currency in USD

Olema Pharmaceuticals Earnings and Revenue History